DK162130C - Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider - Google Patents
Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptiderInfo
- Publication number
- DK162130C DK162130C DK151884A DK151884A DK162130C DK 162130 C DK162130 C DK 162130C DK 151884 A DK151884 A DK 151884A DK 151884 A DK151884 A DK 151884A DK 162130 C DK162130 C DK 162130C
- Authority
- DK
- Denmark
- Prior art keywords
- grf
- analog peptides
- grf analog
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 4
- 101710142969 Somatoliberin Proteins 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 101000825742 Homo sapiens Somatoliberin Proteins 0.000 abstract 2
- 102100022831 Somatoliberin Human genes 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47270083A | 1983-03-07 | 1983-03-07 | |
| US47270083 | 1983-03-07 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK151884D0 DK151884D0 (da) | 1984-03-05 |
| DK151884A DK151884A (da) | 1984-09-08 |
| DK162130B DK162130B (da) | 1991-09-23 |
| DK162130C true DK162130C (da) | 1992-03-02 |
Family
ID=23876594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK151884A DK162130C (da) | 1983-03-07 | 1984-03-05 | Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0121764B1 (da) |
| JP (1) | JPH0786120B2 (da) |
| AT (1) | ATE53220T1 (da) |
| AU (1) | AU574064B2 (da) |
| CA (1) | CA1254000A (da) |
| DE (1) | DE3482387D1 (da) |
| DK (1) | DK162130C (da) |
| IE (1) | IE57097B1 (da) |
| IL (1) | IL71150A (da) |
| NZ (1) | NZ207378A (da) |
| ZA (1) | ZA841638B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518586A (en) * | 1983-01-13 | 1985-05-21 | The Salk Institute For Biological Studies | GRF Analogs III |
| IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
| BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio- Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
| DE3327007A1 (de) * | 1983-07-27 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | Herstellung von polypeptiden mit einem saeureamid-carboxyterminus |
| AU575843B2 (en) * | 1983-08-10 | 1988-08-11 | The Administrators Of The Tulane Eductional Fund | Growth hormone releasing peptides |
| US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
| CA1340265C (en) * | 1985-01-18 | 1998-12-15 | Kirston E. Koths | Oxidation resistant muteins |
| US4734399A (en) * | 1985-08-06 | 1988-03-29 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
| ZA866026B (en) * | 1985-08-12 | 1988-04-27 | Syntex Inc | Bovine growth hormone releasing factor derivative |
| EP0448513A3 (en) * | 1990-03-21 | 1991-12-27 | Japat Ltd | Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
| CA2085362A1 (en) * | 1990-06-29 | 1991-12-30 | Arthur M. Felix | Histidine substituted growth hormone releasing factor analogs |
| DK0490249T3 (da) * | 1990-12-10 | 1995-05-29 | Hoffmann La Roche | Fremgangsmåde til enzymatisk fremstilling af GRF(1-44)-NH2 |
| CA2084061A1 (en) * | 1991-04-09 | 1992-10-10 | Arthur M. Felix | Growth hormone releasing factor analogs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
| US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
-
1984
- 1984-03-05 DK DK151884A patent/DK162130C/da not_active IP Right Cessation
- 1984-03-05 EP EP84102383A patent/EP0121764B1/de not_active Expired - Lifetime
- 1984-03-05 AT AT84102383T patent/ATE53220T1/de not_active IP Right Cessation
- 1984-03-05 IL IL71150A patent/IL71150A/xx not_active IP Right Cessation
- 1984-03-05 ZA ZA841638A patent/ZA841638B/xx unknown
- 1984-03-05 DE DE8484102383T patent/DE3482387D1/de not_active Expired - Fee Related
- 1984-03-05 CA CA000448864A patent/CA1254000A/en not_active Expired
- 1984-03-05 NZ NZ207378A patent/NZ207378A/xx unknown
- 1984-03-05 AU AU25268/84A patent/AU574064B2/en not_active Ceased
- 1984-03-06 IE IE537/84A patent/IE57097B1/en not_active IP Right Cessation
- 1984-03-06 JP JP59041481A patent/JPH0786120B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IE840537L (en) | 1984-09-07 |
| EP0121764A2 (de) | 1984-10-17 |
| JPH0786120B2 (ja) | 1995-09-20 |
| DK151884D0 (da) | 1984-03-05 |
| EP0121764A3 (en) | 1985-12-04 |
| IL71150A0 (en) | 1984-06-29 |
| CA1254000A (en) | 1989-05-09 |
| NZ207378A (en) | 1989-05-29 |
| ZA841638B (en) | 1984-10-31 |
| EP0121764B1 (de) | 1990-05-30 |
| IL71150A (en) | 1987-02-27 |
| JPS59176238A (ja) | 1984-10-05 |
| DK151884A (da) | 1984-09-08 |
| AU574064B2 (en) | 1988-06-30 |
| IE57097B1 (en) | 1992-04-22 |
| DE3482387D1 (en) | 1990-07-05 |
| DK162130B (da) | 1991-09-23 |
| AU2526884A (en) | 1984-09-13 |
| ATE53220T1 (de) | 1990-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK162130C (da) | Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider | |
| DE68928810D1 (de) | Analoge vom menschlichen Insulin | |
| ES8801674A1 (es) | Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante. | |
| DE3852636D1 (de) | Peptid-analoge vom insulinähnlichen wachstums-faktor 1 (igf-1) oder faktor 2 (igf-2). | |
| IL85020A0 (en) | Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it | |
| DE69525544D1 (de) | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose | |
| DE69029377D1 (de) | Substituierungsanaloge von magaininpeptiden | |
| ES2015366A6 (es) | Procedimientos para producir y modificar polipeptidos inhibidores de elastasa y proteinas fusionadas. | |
| ATE111483T1 (de) | Biologisch wirksame moleküle. | |
| KR890010202A (ko) | 사람 단백질 c의 지모겐 형태의 발현용 벡터 및 화합물 | |
| DE3751398D1 (de) | Substrat-Peptide. | |
| DE3650035D1 (de) | THF-Zusammensetzungen. | |
| GB1002041A (en) | New polypeptides and process for their manufacture | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| ATE91286T1 (de) | Gefaessaktive peptide. | |
| LI et al. | Distinct behavior of β‐endorphin and corticotropin toward leucine aminopeptidase action | |
| ATE106944T1 (de) | Rekombinante polypeptide des hämorrhagischen fisch-sepsis-virus. | |
| CA1267086C (en) | METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES | |
| DE59008515D1 (de) | Neue ZNS-aktive Hexapeptide mit antiamnestischer Wirkung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| PBP | Patent lapsed |